MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
1.710
+0.010 (0.59%)
At close: Oct 2, 2025, 4:00 PM EDT
1.720
+0.010 (0.58%)
After-hours: Oct 2, 2025, 5:10 PM EDT

MacroGenics Statistics

Total Valuation

MacroGenics has a market cap or net worth of $108.08 million. The enterprise value is $39.10 million.

Market Cap108.08M
Enterprise Value 39.10M

Important Dates

The next estimated earnings date is Tuesday, November 4, 2025, after market close.

Earnings Date Nov 4, 2025
Ex-Dividend Date n/a

Share Statistics

MacroGenics has 63.21 million shares outstanding. The number of shares has increased by 1.07% in one year.

Current Share Class 63.21M
Shares Outstanding 63.21M
Shares Change (YoY) +1.07%
Shares Change (QoQ) +0.27%
Owned by Insiders (%) 2.39%
Owned by Institutions (%) 62.29%
Float 52.56M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.65
Forward PS 2.02
PB Ratio 2.32
P/TBV Ratio 2.32
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 0.24
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.26, with a Debt / Equity ratio of 2.31.

Current Ratio 5.26
Quick Ratio 4.85
Debt / Equity 2.31
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -89.69

Financial Efficiency

Return on equity (ROE) is -69.71% and return on invested capital (ROIC) is -39.65%.

Return on Equity (ROE) -69.71%
Return on Assets (ROA) -21.84%
Return on Invested Capital (ROIC) -39.65%
Return on Capital Employed (ROCE) -37.80%
Revenue Per Employee $485,323
Profits Per Employee -$106,742
Employee Count341
Asset Turnover 0.74
Inventory Turnover 34.95

Taxes

In the past 12 months, MacroGenics has paid $1.05 million in taxes.

Income Tax 1.05M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -50.15% in the last 52 weeks. The beta is 1.61, so MacroGenics's price volatility has been higher than the market average.

Beta (5Y) 1.61
52-Week Price Change -50.15%
50-Day Moving Average 1.66
200-Day Moving Average 1.96
Relative Strength Index (RSI) 51.78
Average Volume (20 Days) 799,094

Short Selling Information

The latest short interest is 3.73 million, so 5.90% of the outstanding shares have been sold short.

Short Interest 3.73M
Short Previous Month 3.76M
Short % of Shares Out 5.90%
Short % of Float 7.10%
Short Ratio (days to cover) 3.89

Income Statement

In the last 12 months, MacroGenics had revenue of $165.50 million and -$36.40 million in losses. Loss per share was -$0.58.

Revenue165.50M
Gross Profit -16.09M
Operating Income -78.03M
Pretax Income -35.35M
Net Income -36.40M
EBITDA -70.46M
EBIT -78.03M
Loss Per Share -$0.58
Full Income Statement

Balance Sheet

The company has $176.49 million in cash and $107.51 million in debt, giving a net cash position of $68.98 million or $1.09 per share.

Cash & Cash Equivalents 176.49M
Total Debt 107.51M
Net Cash 68.98M
Net Cash Per Share $1.09
Equity (Book Value) 46.62M
Book Value Per Share 0.74
Working Capital 165.95M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$72.12 million and capital expenditures -$2.46 million, giving a free cash flow of -$74.58 million.

Operating Cash Flow -72.12M
Capital Expenditures -2.46M
Free Cash Flow -74.58M
FCF Per Share -$1.18
Full Cash Flow Statement

Margins

Gross margin is -9.72%, with operating and profit margins of -47.15% and -21.99%.

Gross Margin -9.72%
Operating Margin -47.15%
Pretax Margin -21.36%
Profit Margin -21.99%
EBITDA Margin -42.58%
EBIT Margin -47.15%
FCF Margin n/a

Dividends & Yields

MacroGenics does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1.07%
Shareholder Yield -1.07%
Earnings Yield -33.68%
FCF Yield -69.00%

Analyst Forecast

The average price target for MacroGenics is $3.20, which is 87.14% higher than the current price. The consensus rating is "Hold".

Price Target $3.20
Price Target Difference 87.14%
Analyst Consensus Hold
Analyst Count 6
Revenue Growth Forecast (5Y) -0.40%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

MacroGenics has an Altman Z-Score of -6.13 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -6.13
Piotroski F-Score 3